Literature DB >> 567585

The effects of naltrexone on the development of physical dependence on morphine.

H N Bhargava.   

Abstract

A single i.p. injection of naltrexone (20 mg/kg) partially inhibited the development of physical dependence upon morphine in mice rendered dependent on morphine by implantation of a pellet containing 75 mg of morphine free base for three days. This was evidenced by an increase in the dose of naloxone (ED50) required to precipitate withdrawal jumping response. The increase in naloxone ED50 was much more pronounced when naltrexone was given prior to and during the course of pellet implantation. Inhibition was also observed when naltrexone was administered one day after the morphine pellet implantation, i.e., after some dependence had already developed. Naltrexone administration prior to and during the development of dependence also inhibited, but only partially, the loss of body weight and hypothermic response observed during abrupt withdrawal of morphine in morphine-dependent mice. The inhibitory effect of naltrexone on morphine dependence development was not associated with changes in brain morphine concentration.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567585     DOI: 10.1016/0014-2999(78)90351-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

Authors:  S M Crain; K F Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

2.  Blockage of narcotic-induced dopamine receptor supersensitivity by cyclo(Leu-Gly).

Authors:  R F Ritzmann; R Walter; H N Bhargava; L B Flexner
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Pharmacological characterization of opiate physical dependence in the isolated ileum of the guinea-pig.

Authors:  M Luján; R Rodríguez
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

Review 4.  Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Authors:  J P Gonzalez; R N Brogden
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

5.  The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration.

Authors:  H N Bhargava
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice.

Authors:  D Matthew Walentiny; Essie Komla; Léa T Moisa; Mohammed A Mustafa; Justin L Poklis; Hamid I Akbarali; Patrick M Beardsley
Journal:  Neuropharmacology       Date:  2020-12-11       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.